Biodexa Pharmaceuticals Plc (BDRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 | Q4'16 | Q2'16 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 83K | 298K | 231K | 468K | 177K | 401K | 175K | 168K | 222K | 452K | 1.39M | 549K | 516K | 473K | -3.61M | 2.95M |
| Revenue Growth % | - | - | -100% | -100% | -64.07% | -36.32% | 30.51% | 16.71% | 1.14% | 138.69% | -21.17% | -62.83% | -84.02% | -17.67% | 169.19% | 16.07% | 114.28% | -83.97% | -443.86% | 810.8% |
| Cost of Goods Sold | 48.7K | 1.67M | 3.25M | 2.19M | 2.25M | 2.25M | 2.7M | 2.41M | 2.64M | 2.01M | 3.82M | 3.99M | 4.38M | 3.46M | 4.76M | 4.59M | 4.16M | 4.17M | 7.31M | 180K |
| COGS % of Revenue | - | - | - | - | 2712.05% | 755.37% | 1167.97% | 515.6% | 1493.79% | 501.25% | 2182.29% | 2374.4% | 1974.77% | 765.27% | 342.98% | 836.98% | 805.81% | 881.82% | -202.17% | 6.1% |
| Gross Profit | -48.7K | -1.67M | -3.25M | -2.19M | -2.17M | -1.95M | -2.47M | -1.95M | -2.47M | -1.61M | -3.64M | -3.82M | -4.16M | -3.01M | -3.38M | -4.05M | -3.64M | -3.7M | -10.92M | 2.77M |
| Gross Margin % | - | - | - | - | -2612.05% | -655.37% | -1067.97% | -415.6% | -1393.79% | -401.25% | -2082.29% | -2274.4% | -1874.77% | -665.27% | -242.98% | -736.98% | -705.81% | -781.82% | 302.17% | 93.9% |
| Gross Profit Growth % | 98.5% | 23.94% | -49.82% | -12.08% | 12.12% | -0.41% | 0% | -20.88% | 32.3% | 57.89% | 12.45% | -27.07% | -23.32% | 25.68% | 7.33% | -9.41% | 66.65% | -233.45% | -1213.2% | 755.25% |
| Operating Expenses | 4.68M | 2.35M | 1.73M | 4.22M | 1.6M | 1.9M | 2.62M | 1.44M | 227K | 1.76M | 1.96M | 14.02M | 1.43M | 2.24M | 2.17M | 2.22M | 2.6M | 2.94M | 22.32M | 13.11M |
| OpEx % of Revenue | - | - | - | - | 1930.12% | 639.26% | 1132.9% | 306.62% | 128.25% | 438.65% | 1117.14% | 8343.45% | 643.24% | 494.91% | 156.23% | 405.1% | 504.07% | 620.51% | -617.47% | 444.12% |
| Selling, General & Admin | 2.46M | 2.38M | 1.76M | 2.03M | 741K | 2.29M | 1.33M | 1.85M | 1.29M | 1.66M | 2.75M | 2.93M | 1.93M | 2.24M | 2.17M | 2.22M | 1.5M | 2.94M | 11.1M | 11.06M |
| SG&A % of Revenue | - | - | - | - | 892.77% | 768.79% | 577.06% | 395.09% | 728.81% | 412.97% | 1568.57% | 1745.83% | 868.02% | 494.91% | 156.23% | 405.1% | 290.89% | 620.51% | -307.15% | 374.72% |
| Research & Development | 2.28M | 1.67M | 3.25M | 2.19M | 1.82M | 2.25M | 2.7M | 2.41M | 2.64M | 2.01M | 12.16M | 3.99M | 4.38M | 3.46M | 4.76M | 4.59M | 5.66M | 4.17M | 2.81M | 2.05M |
| R&D % of Revenue | - | - | - | - | 2187.95% | 755.37% | 1167.97% | 515.6% | 1493.79% | 501.25% | 6946.86% | 2374.4% | 1974.77% | 765.27% | 342.98% | 836.98% | 1096.51% | 881.82% | -77.7% | 69.4% |
| Other Operating Expenses | -63.85K | -1000K | -1000K | 0 | -955K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.72M | -4.02M | -4.98M | -4.22M | -3.77M | -4.24M | -3.79M | -3.78M | -3.76M | -3.23M | -6.38M | -6.75M | -6.07M | -5.24M | -5.54M | -6.27M | -5.14M | -6.63M | 5.1M | -10.34M |
| Operating Margin % | - | - | - | - | -4542.17% | -1424.16% | -1642.42% | -807.26% | -2126.55% | -806.48% | -3644% | -4020.24% | -2736.04% | -1160.18% | -399.21% | -1142.08% | -996.71% | -1402.33% | -141.17% | -350.22% |
| Operating Income Growth % | 5.05% | 4.9% | -31.99% | 0.49% | 0.63% | -12.33% | -0.8% | -16.82% | 40.98% | 52.12% | -4.99% | -28.79% | -9.54% | 16.36% | -7.82% | 5.47% | -200.8% | 35.82% | 205.72% | -96.26% |
| EBITDA | -4.68M | -3.94M | -4.93M | -4.09M | -3.7M | -4.17M | -3.71M | -3.68M | -3.67M | -3.12M | -5.75M | -6.28M | -5.31M | -4.73M | -5.36M | -5.34M | -3.87M | -5.35M | 6.2M | -8.18M |
| EBITDA Margin % | - | - | - | - | -4454.22% | -1399.66% | -1607.36% | -786.75% | -2072.32% | -777.31% | -3286.86% | -3738.1% | -2390.54% | -1045.58% | -386.03% | -973.04% | -749.03% | -1131.92% | -171.6% | -277.33% |
| EBITDA Growth % | 5.09% | 3.47% | -33.27% | 2.01% | 0.43% | -13.28% | -1.23% | -18.13% | 36.23% | 50.37% | -8.39% | -32.88% | 1.03% | 11.53% | -38.73% | 0.22% | -162.32% | 34.58% | 244.86% | -61.26% |
| D&A (Non-Cash Add-back) | 48.7K | 71K | 49K | 136K | 73K | 73K | 81K | 96K | 96K | 117K | 625K | 474K | 767K | 518K | 183K | 928K | 1.28M | 1.28M | 1.1M | 2.15M |
| EBIT | -4.72M | -4.02M | -4.98M | -3.38M | -2.36M | -4.24M | -3.79M | -3.78M | -3.76M | -3.23M | -6.38M | -6.75M | -5.58M | -5.24M | -5.54M | -6.27M | -5.14M | -6.63M | 5.1M | -10.34M |
| Net Interest Income | 32.8K | -100K | -37K | 39K | 40K | 2K | 6K | 18K | 22K | 22K | 12K | 21K | -89K | 0 | -585K | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 53.67K | 0 | 0 | 88K | 40K | 2K | 6K | 18K | 22K | 22K | 12K | 21K | 82K | 7K | 346K | 239K | 47K | 47K | 337K | 765K |
| Interest Expense | 20.87K | 100K | 37K | 49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97K | 0 | 587K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.22M | 45K | 2.43M | 790K | 141K | 388K | 64K | 380K | 1.05M | -156K | -916K | 486K | 402K | -7K | -346K | -239K | 353K | -47K | 5.96M | 765K |
| Pretax Income | -2.5M | -3.97M | -2.55M | -3.43M | -3.63M | -3.86M | -5.09M | -3.4M | -2.72M | -3.39M | -5.61M | -17.86M | -5.67M | -5.25M | -5.89M | -6.51M | -6.29M | -6.68M | 11.06M | -9.57M |
| Pretax Margin % | - | - | - | - | -4372.29% | -1293.96% | -2203.46% | -726.07% | -1534.46% | -845.39% | -3206.29% | -10630.36% | -2554.95% | -1161.73% | -424.12% | -1185.61% | -1218.99% | -1412.26% | -305.98% | -324.3% |
| Income Tax | 59.63K | 165K | -125K | -125K | -118K | -288K | -495K | -337K | -410K | -236K | -842K | -439K | -953K | -832K | -1.14M | -889K | -621K | -644K | 3.04M | -1.36M |
| Effective Tax Rate % | -2.38% | -4.16% | 4.91% | 3.64% | 3.25% | 7.47% | 9.72% | 9.92% | 15.1% | 6.96% | 15.01% | 2.46% | 16.8% | 15.84% | 19.4% | 13.66% | 9.87% | 9.64% | 27.45% | 14.26% |
| Net Income | -2.56M | -3.81M | -2.42M | -3.31M | -3.51M | -3.57M | -4.59M | -3.06M | -2.31M | -3.15M | -4.77M | -17.42M | -4.72M | -4.42M | -4.75M | -5.62M | -5.67M | -6.04M | 8.02M | -8.21M |
| Net Margin % | - | - | - | - | -4230.12% | -1197.32% | -1989.18% | -654.06% | -1302.82% | -786.53% | -2725.14% | -10369.05% | -2125.68% | -977.65% | -341.83% | -1023.68% | -1098.64% | -1276.11% | -221.98% | -278.04% |
| Net Income Growth % | -5.83% | -15.05% | 31.05% | 7.29% | 23.59% | -16.56% | -99.26% | 2.95% | 51.65% | 81.89% | -1.06% | -294.21% | 0.61% | 21.37% | 16.25% | 6.89% | -170.66% | 26.44% | 254.13% | -67.65% |
| Net Income (Continuing) | -2.56M | -4.14M | -2.42M | -3.31M | -3.51M | -3.57M | -4.59M | -3.06M | -2.31M | -3.15M | -4.77M | -17.42M | -4.72M | -4.42M | -4.75M | -5.62M | -5.67M | -6.04M | -5.98M | -8.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -999999.00 | -365000.00 | -792000.00 | -113000.00 | -219000.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | 999999.00 | -999999.00 |
| EPS Growth % | 100% | -90.15% | -223.01% | -261.64% | 96.19% | 88.92% | -99.26% | 2.95% | 51.64% | 96.38% | 83.17% | 60.59% | 93.98% | 21.37% | -65.99% | 6.89% | -170.66% | 26.44% | 254.13% | -67.65% |
| EPS (Basic) | 0.00 | -999999.00 | -365000.00 | -792000.00 | -113000.00 | -219000.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | 999999.00 | -999999.00 |
| Diluted Shares Outstanding | 225.82K | 252.67K | 61.95K | 2.48K | 30 | 7 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Shares Outstanding | 225.82K | 252.67K | 61.95K | 2.48K | 30 | 7 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |